Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer

Abstract Objective To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based therapy. Methods This was an open-label, single-arm and multicenter clin...

Full description

Bibliographic Details
Main Authors:	Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng, Guiling Li, Changzhong Li, Huirong Shi, Yaqing Chen
Format:	Article
Language:	English
Published:	BMC 2021-01-01
Series:	Journal of Ovarian Research
Subjects:	CA125 Pegylated liposomal doxorubicin Platinum-refractory relapse Platinum-resistant relapse Partially platinum-sensitive relapse
Online Access:	https://doi.org/10.1186/s13048-020-00736-2

Similar Items

A Survival Analysis of Patients with Recurrent Epithelial Ovarian Cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia
by: Lilit Harutyunyan, et al.
Published: (2024-03-01)

A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage Treatment in Refractory or Relapsed Small Cell Lung Cancer
by: Shufei YU, et al.
Published: (2013-09-01)

Novel inflammatory markers and prognostic importance of platinum-sensitive ovarian carcinoma relapse
by: Tay Fatih, et al.
Published: (2023-01-01)

Introduction to managing patients with recurrent ovarian cancer
by: Hani Gabra
Published: (2014-12-01)

Long-term effect of pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer: а clinical case
by: I. A. Pokataev, et al.
Published: (2015-11-01)

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
by: William P. McGuire, et al.
Published: (2018-12-01)

Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I studyResearch in context
by: Suying Lu, et al.
Published: (2024-07-01)

Targeting autophagy in platinum-sensitive relapsed ovarian cancer: randomized phase II trial of hydroxychloroquine with chemotherapy with biomarker correlation
by: Luxitaa Goenka, et al.
Published: (2025-02-01)

Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
by: E. G. Novikova, et al.
Published: (2014-07-01)

Practical aspects of treating relapsed BRCA-associated ovarian cancer
by: A. A. Rumyantse, et al.
Published: (2019-12-01)

Limitations to the use of carboplatin-based therapy in advanced ovarian cancer
by: Christina Fotopoulou
Published: (2014-12-01)

Stromal cell ratio based on automated image analysis as a predictor for platinum-resistant recurrent ovarian cancer
by: C. Lan, et al.
Published: (2019-02-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Logam-logam platinum/
by: 237959 Misliah Masari

Engineering Novel Amphiphilic Platinum(IV) Complexes to Co-Deliver Cisplatin and Doxorubicin
by: Wjdan Jogadi, et al.
Published: (2024-08-01)

Preparation of platinum/electrogenerated zinc supported on zeolite beta for n-pentane isomerization /
by: Nur Hidayatul Nazirah Kamarudin, 1987-, et al.
Published: (2011)

The impact of cold deformation, annealing temperatures and chemical assays on the mechanical properties of platinum
by: Trumić B., et al.
Published: (2010-01-01)

Changes in Pt-Rh catalysts in the working environment
by: Trumić Biserka, et al.
Published: (2015-01-01)

Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia
by: Han Yao, et al.
Published: (2023-06-01)

Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
by: Hisham O. Akbar, et al.
Published: (2002-04-01)

Platinum metals review
Published: ([19-)

Ovarian Cancer—Insights into Platinum Resistance and Overcoming It
by: Andrei Havasi, et al.
Published: (2023-03-01)

Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer
by: María Jesús Rubio Pérez
Published: (2017-05-01)

Mapping global platinum supply chain and assessing potential supply risks
by: Pengyuan Li, et al.
Published: (2023-01-01)

Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i>p</i>-BrC<sub>6</sub>F<sub>4</sub>)NCH<sub>2</sub>CH<sub>2</sub>NEt<sub>2</sub>}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide
by: Ruchika Ojha, et al.
Published: (2023-09-01)

Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
by: Weng CS, et al.
Published: (2019-11-01)

Platinum Resistance in Ovarian Cancer: Limitations of PFI Binary Classification and Potential Improvements
by: Xiaoyu LI, et al.
Published: (2024-10-01)

Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data
by: Kemin Li, et al.
Published: (2024-01-01)

Comparative study of ethanol oxidation at Pt: Based nanoalloys and UPD modified Pt nanoparticles
by: Tripković Amalija V., et al.
Published: (2010-01-01)

Synthetic and spectroscopic studies on heterometallic clusters of platinum
by: Hallam, M, et al.
Published: (1986)

The effect of impurities on high-temperature resistance of platinum and its alloys
by: Trumić Biserka, et al.
Published: (2015-01-01)

Electrocatalysts for the Oxygen Reduction Reaction: From Bimetallic Platinum Alloys to Complex Solid Solutions
by: Ricardo Martínez-Hincapié, et al.
Published: (2022-02-01)

The ayrton metals platinum year book 1992/
by: Nathan, Brian H
Published: (1992)

Chemistry of the platinum group metals : recent developments/
by: Hartley, F. R.
Published: (1991)

The chemistry of platinum and palladium : with particular reference to complexes of elements/
by: 220602 Hartley, F. R.
Published: (1973)

Platinum group metals and compounds
Published: (1971)

Analytical chemistry of platinum metals
by: Ginzburg, S. I.
Published: (1975)

Outcome of MS relapses in the era of disease-modifying therapy
by: Muriel Stoppe, et al.
Published: (2017-08-01)

Tangeretin-Assisted Platinum Nanoparticles Enhance the Apoptotic Properties of Doxorubicin: Combination Therapy for Osteosarcoma Treatment
by: Sangiliyandi Gurunathan, et al.
Published: (2019-07-01)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
by: Yan Rong, et al.
Published: (2021-01-01)